Without Acquisition, Acadia Healthcare Shares Remain Overvalued
July 28, 2016 at 11:37 AM EDT
Without acquisition hopes, the expectations baked into the current stock price remain unrealistically high. Specifically, to justify the current price of $55/share, ACHC must grow NOPAT by 14% compounded annually for the next 12 years.